Phadnis et al., 2015 - Google Patents
Dynamic and social behaviors of human pluripotent stem cellsPhadnis et al., 2015
View HTML- Document ID
- 12584970975225082795
- Author
- Phadnis S
- Loewke N
- Dimov I
- Pai S
- Amwake C
- Solgaard O
- Baer T
- Chen B
- Pera R
- Publication year
- Publication venue
- Scientific Reports
External Links
Snippet
Human pluripotent stem cells (hPSCs) can self-renew or differentiate to diverse cell types, thus providing a platform for basic and clinical applications. However, pluripotent stem cell populations are heterogeneous and functional properties at the single cell level are poorly …
- 210000001778 pluripotent stem cell 0 title abstract description 20
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Veres et al. | Charting cellular identity during human in vitro β-cell differentiation | |
Phadnis et al. | Dynamic and social behaviors of human pluripotent stem cells | |
Liu et al. | Modelling human blastocysts by reprogramming fibroblasts into iBlastoids | |
Paull et al. | Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells | |
Park et al. | Extracellular matrix anisotropy is determined by TFAP2C-dependent regulation of cell collisions | |
Shahbazi et al. | Developmental potential of aneuploid human embryos cultured beyond implantation | |
Posfai et al. | Evaluating totipotency using criteria of increasing stringency | |
Ibarra-Soria et al. | Defining murine organogenesis at single-cell resolution reveals a role for the leukotriene pathway in regulating blood progenitor formation | |
Semrau et al. | Dynamics of lineage commitment revealed by single-cell transcriptomics of differentiating embryonic stem cells | |
Agoglia et al. | Primate cell fusion disentangles gene regulatory divergence in neurodevelopment | |
Hu et al. | Induction of mouse totipotent stem cells by a defined chemical cocktail | |
Dorrell et al. | Human islets contain four distinct subtypes of β cells | |
Del Mármol et al. | Piezo1 forms a slowly-inactivating mechanosensory channel in mouse embryonic stem cells | |
Chitiashvili et al. | Female human primordial germ cells display X-chromosome dosage compensation despite the absence of X-inactivation | |
Vishnoi et al. | The isolation and characterization of CTC subsets related to breast cancer dormancy | |
Parr et al. | MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells | |
Shakiba et al. | CD24 tracks divergent pluripotent states in mouse and human cells | |
Tsutsui et al. | An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells | |
Konagaya et al. | Long-term maintenance of human induced pluripotent stem cells by automated cell culture system | |
Bao et al. | Stem cell-derived synthetic embryos self-assemble by exploiting cadherin codes and cortical tension | |
Li et al. | Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells | |
Xie et al. | Similar morphological and molecular signatures shared by female and male germline stem cells | |
Lavagi et al. | Single-cell RNA sequencing reveals developmental heterogeneity of blastomeres during major genome activation in bovine embryos | |
Kang et al. | Embryonic and induced pluripotent stem cell staining and sorting with the live-cell fluorescence imaging probe CDy1 | |
Cote et al. | Single-cell differences in matrix gene expression do not predict matrix deposition |